Back to Trades
Cross Shawn
Chief Financial OfficerCIK 0001734779
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Cross Shawn, Chief Financial Officer, has filed 6 SEC reports (2025–2026), all concentrated in Pacira BioSciences, Inc. (PCRX), totaling $9.4M in disclosed volume. Weighing $0 bought versus $1.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Nov 17 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Disposed | $6.0M |
| Nov 3 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Tax withheld | $347.2K |
| Apr 24 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Sell | $325.6K |
| Apr 22 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Sell | $302.6K |
| Dec 11 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Sell | $626.8K |
| Nov 3 | PCRX Pacira BioSciences, Inc. | Cross Shawn | Chief Financial Officer | Tax withheld | $143.0K |
6 filings